Speciality: Oncology
Description:
A warm welcome to all the medical professionals in this interesting learning session on understanding the best treatment approaches of ALK positive lung cancer.
In this webinar, a panel discussion would take place involving Dr. Todd Bauer as the primary speaker and Dr. Ullas Batra as a moderator who will share the important facts associated with treatment approaches for management of ALK positive lung cancer.
Dr. Todd Bauer has explained all details associated with the incidence, progression and treatment of ALK positive lung cancer. Further, a discussion on all possible treatment approaches and their pros, cons are discussed.
ALK-positive lung cancer represents about 4% of lung cancer which generally appears in adenocarcinoma non-small cell lung cancer. Patients with ALK-positive are mostly younger than the average lung cancer patient and also do not have a smoking history compared to other lung cancers.
Therefore, you are going to have an overall knowledge regarding management of ALK positive lung cancer. Listen to the webinar, grab the knowledge that is shared and follow HiDoc for more such interesting webinar sessions.
See More Webinars @ Hidoc Webinars
1.
CDC Alerts on Dramatic Rise in Human Parvovirus B19
2.
What Patients Hear From Us: 'Blah, Blah, Tumor, Blah, Blah, Cancer'
3.
Health of Myeloma Patient's Marriage Tied to Recovery After Transplant
4.
Adding SBRT to systemic therapy could boost outcomes for some locally advanced hepatocellular carcinoma patients
5.
Joe Biden has prostate cancer with bone spread. An oncologist explains what you need to know
1.
Potential of Device-Assisted Therapy in Non-Muscle-Invasive Bladder Cancer
2.
Getting to Know RDW and SD: How They Relate to Anemia, Inflammation, and More
3.
Case Study: The Role of Machine Learning in the Detection of Skin Cancer
4.
The Silent Killer: Uncovering the Causes and Treatments of Hemorrhagic Gastritis
5.
The Future of Hemophilia Treatment: Long-Acting Therapies and Gene Editing
1.
International Lung Cancer Congress®
2.
Future NRG Oncology Meeting
3.
Genito-Urinary Oncology Summit 2026
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
Dacomitinib Case Presentation: Baseline Treatment and Current Status
2.
Breaking Down PALOMA-2: How CDK4/6 Inhibitors Redefined Treatment for HR+/HER2- Metastatic Breast Cancer
3.
Navigating the Complexities of Ph Negative ALL - Part II
4.
Iron Deficiency Anemia: Ferric Maltol As a New Treatment Option- Summarization of the New Perspective
5.
Current Scenario of Blood Cancer- A Conclusion on Genomic Testing & Advancement in Diagnosis and Treatment
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation